Celularity Inc. (CELU)
NASDAQ: CELU
· Real-Time Price · USD
2.13
0.09 (4.41%)
At close: Oct 03, 2025, 3:59 PM
2.12
-0.47%
After-hours: Oct 03, 2025, 04:10 PM EDT
Celularity Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License, Royalty and Other Revenue | 2.47M | 9.02M | 9.14M | 3.39M | 9.96M | 12.84M | 12.59M | 557K | 906K | 1.04M | 829K | 812K | 1.23M | 651K | 1.07M | 849K |
| License, Royalty and Other Revenue Growth | -72.59% | -1.30% | +169.29% | -65.94% | -22.42% | +1.99% | +2160.68% | -38.52% | -13.14% | +25.81% | +2.09% | -33.88% | +88.63% | -38.99% | +25.68% | n/a |
| Product Revenue | 2.55M | 1.41M | 1.28M | 1.29M | 1.28M | 1.29M | 5.04M | 398K | 1.28M | 1.36M | 1.45M | 899K | 1.37M | 1.28M | 1.32M | 1.34M |
| Product Revenue Growth | +81.11% | +9.74% | -0.70% | +1.10% | -0.70% | -74.48% | +1167.09% | -68.86% | -5.82% | -6.48% | +61.40% | -34.52% | +7.01% | -2.66% | -1.86% | n/a |
| Service Revenue | 1.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 12.63M | 14.26M | 16.06M | 12.65M | 15.91M | 14.03M | 13.07M | 10.75M | 12.83M | 13.93M | 19.08M | 14.91M | 15.57M | 16.46M | 13.21M | 21.64M | 28.86M | 7.63M | 5.97M | 8.33M | 7.59M | 241.64K | 246.96K | 202K | 115.25K | 121 |
| Selling, General, and Administrative Revenue Growth | -11.41% | -11.18% | +26.94% | -20.48% | +13.39% | +7.35% | +21.59% | -16.20% | -7.95% | -26.97% | +27.99% | -4.28% | -5.38% | +24.62% | -38.98% | -25.01% | +278.48% | +27.67% | -28.27% | +9.77% | +3039.39% | -2.16% | +22.26% | +75.27% | +95147.93% | n/a |
| Research and Development Revenue | 3.35M | 3.73M | 3.83M | 3.92M | 3.8M | 5.84M | -272K | 3.39M | 8.6M | 16.95M | 10.99M | 20.35M | 25.35M | 19.93M | 22.63M | 23.77M | 22.91M | 16.99M | 13.92M | 11.22M | 15.8M | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -10.09% | -2.61% | -2.22% | +3.03% | -34.96% | -2248.16% | -108.02% | -60.58% | -49.24% | +54.24% | -46.00% | -19.72% | +27.19% | -11.94% | -4.76% | +3.73% | +34.85% | +22.02% | +24.13% | -29.02% | n/a | n/a | n/a | n/a | n/a | n/a |